Urge federal health and border agencies to delay new prescription-medicine import procedures unless they can assure continued entry of genuine personal-use prescription medicines that do not present unreasonable risk.

Delia C. Ramirez · Illinois · Democratic

oversight impact 0.55 specificity 0.78 extraction confidence 77%

Commitment kind: action. Promised action: Urge HHS, FDA, DHS, and CBP to delay implementation of new prescription-medicine procedures unless they assure continued entry of genuine personal-use prescription medicines that do not present unreasonable risk.. Promised outcome: Preserve Americans' access to safe and affordable personal-use prescription medicines from outside the United States.. Deadline: unknown; not assumed expired. As a signer of an October 2, 2026 congressional letter while serving as U.S. Representative for Illinois's 3rd District.

Contest this claim

Occurrences

“We urge HHS, FDA, DHS, and CBP to delay any implementation of new procedures with respect to prescription medicines unless you can provide clear assurances that your agencies will not prevent genuine prescription medicines clearly intended for personal use and not appearing to present an unreasonable risk from entering the United States,” the members added.

Ramirez joined other House members in urging federal agencies to delay new procedures affecting prescription medicines unless they assure continued access to genuine personal-use prescriptions from abroad.

Schakowsky, Pocan Lead 71 Members Calling for Continued Allowance of Prescription Drug Imports | Congresswoman Jan Schakowsky
primary · press_release · model gpt-5.5

Evidence

unverified · Source version 79214 · locator unknown

“We urge HHS, FDA, DHS, and CBP to delay any implementation of new procedures with respect to prescription medicines”

Unverified model/legacy excerpt; not proof. AI summary (separate from source): Official House release says members urged HHS, FDA, DHS, and CBP to delay implementation of new prescription-medicine procedures unless safeguards were assured.

delivered same_term A for effort

Schakowsky, Pocan Lead 71 Members Calling for Continued Allowance of Prescription Drug Imports | Congresswoman Jan Schakowsky
primary · model gpt-5.5 · confidence 94%

Contest this evidence item

unverified · Source version 79214 · locator unknown

“Mike Quigley (IL-05), Delia Ramirez (IL-03), Emily Randall (WA-06)”

Unverified model/legacy excerpt; not proof. AI summary (separate from source): The same official release lists Delia Ramirez among the 71 signers of the letter, tying her to the oversight request.

delivered same_term A for effort

Schakowsky, Pocan Lead 71 Members Calling for Continued Allowance of Prescription Drug Imports | Congresswoman Jan Schakowsky
primary · model gpt-5.5 · confidence 93%

Contest this evidence item

unverified · Source version 90750 · locator unknown

“We urge HHS, FDA, DHS, and CBP to delay any implementation of new procedures with respect to prescription medicines unless you can provide clear assurances”

Unverified model/legacy excerpt; not proof. AI summary (separate from source): Official House release states that the members urged HHS, FDA, DHS, and CBP to delay new prescription-medicine procedures absent assurances protecting personal-use medicines.

delivered same_term A for effort

Pocan, Schakowsky Lead 71 Members Calling for Continued Allowance of Prescription Drug Imports | Congressman Mark Pocan
secondary · model gpt-5.5 · confidence 95%

Contest this evidence item

unverified · Source version 90750 · locator unknown

“Mike Quigley (IL-05), Delia Ramirez (IL-03), Emily Randall (WA-06)”

Unverified model/legacy excerpt; not proof. AI summary (separate from source): The official House release lists Delia Ramirez among the 71 signers, tying her directly to the oversight letter.

delivered same_term A for effort

Pocan, Schakowsky Lead 71 Members Calling for Continued Allowance of Prescription Drug Imports | Congressman Mark Pocan
secondary · model gpt-5.5 · confidence 94%

Contest this evidence item

Assessments

No assessments yet.